Rational Development of 4-Aminopyridyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51 as Anti-Chagas Agents
about
Expanding the Binding Envelope of CYP51 Inhibitors TargetingTrypanosoma cruziwith 4-Aminopyridyl-Based Sulfonamide DerivativesR -Configuration of 4-Aminopyridyl-Based Inhibitors of CYP51 Confers Superior Efficacy Against Trypanosoma cruzi4-Aminopyridyl-Based CYP51 Inhibitors as Anti- Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo PotencyThe Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking InvestigationsTargeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylaseUtilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas DiseaseDrug strategies targeting CYP51 in neglected tropical diseasesBinding mode and potency of N-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting Trypanosoma cruzi CYP51.Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi.Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.3-pyridyl inhibitors with novel activity against Trypanosoma cruzi reveal in vitro profiles can aid prediction of putative cytochrome P450 inhibition.
P2860
Q27683570-DEAAF2DC-BE4E-4CD7-918D-7E2AF33237C0Q27684247-67E9E74A-E91A-48A1-ACC1-B6E1CABB635BQ27684956-F80E919E-0659-4D56-B012-FCD8A0B30283Q28066944-9FA1002C-34A4-47BE-A078-D6C7423E3AF8Q28544037-F0BD4A50-5CE7-4BA8-974B-2F94B0D9B02EQ28546644-311C0AE8-01D3-4792-AB29-73DA28EC1837Q34622554-5C3DB79F-B8E1-44F3-9C11-C68F25D618E2Q34701325-9D333224-CC92-47DD-8009-39A16C009270Q36808252-15DB7C3A-AAC2-4EA0-AB3A-2DB5C0F5EECFQ39165581-433196BE-585A-489E-B3E4-883BEB9DC305Q41073713-544276BB-0932-475E-9613-83B2479F5115Q48342608-F776BE15-6B41-4A6C-B119-1954273706D1Q52646076-A94F85E6-63DB-4DDB-A7E2-6D87FEBFB5DB
P2860
Rational Development of 4-Aminopyridyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51 as Anti-Chagas Agents
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@ast
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@en
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@nl
type
label
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@ast
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@en
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@nl
prefLabel
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@ast
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@en
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@nl
P2093
P2860
P921
P3181
P356
P1476
Rational Development of 4-Amin ...... zi CYP51 as Anti-Chagas Agents
@en
P2093
Claudia M Calvet
Claudia Ruiz
Jun Yong Choi
Larissa M Podust
Michael D Cameron
Shamila S Gunatilleke
William R Roush
P2860
P304
P3181
P356
10.1021/JM401067S
P407
P577
2013-10-10T00:00:00Z